Anticholinergic Use for OAB in the Older Woman: An Update-Reference-Cited by-同舟云学术

Anticholinergic Use for OAB in the Older Woman: An Update

Published:2023-03-01 Issue:2 Volume:12 Page:13-21
ISSN:2196-7865
Container-title:Current Geriatrics Reports
language:en
Short-container-title:Curr Geri Rep

Author:

Davis Berkley,Chen Katherina,Markert Olivia,Zillioux Jacqueline^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology

Link

https://link.springer.com/content/pdf/10.1007/s13670-023-00380-w.pdf

Reference53 articles.

1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26. https://doi.org/10.1007/s00192-009-0976-9

2. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National Community Prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77:1081–7. https://doi.org/10.1016/j.urology.2010.08.039

3. Lai HH, Shen B, Rawal A, Vetter J. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. BMC Urol. 2016;16:60. https://doi.org/10.1186/s12894-016-0179-x

4. Onukwugha E, Zuckerman IH, McNally D, Coyne KS, Vats V, Mullins CD. The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care. 2009;15:90–7.

5. Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (Non-Neurogenic) in adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019;202:558–63. https://doi.org/10.1097/JU.0000000000000309